指南解读

特殊情况下的肺血栓栓塞症诊断和治疗——2018年《肺血栓栓塞症诊治与预防指南》解读

展开
  • 中日友好医院呼吸中心 呼吸与危重症医学科,中国医学科院呼吸病学研究院,国家呼吸病研究中心,北京 100029

收稿日期: 2019-02-27

  网络出版日期: 2019-02-25

本文引用格式

万钧, 翟振国 . 特殊情况下的肺血栓栓塞症诊断和治疗——2018年《肺血栓栓塞症诊治与预防指南》解读[J]. 诊断学理论与实践, 2019 , 18(1) : 34 -36 . DOI: 10.16150/j.1671-2870.2019.01.007

参考文献

[1] 中华医学科会呼吸病学分会肺栓塞与肺血管学组, 中国医师协会呼吸医师分会肺栓塞与肺血管病工作委员会, 全国肺栓与肺血管病防治协作组. 肺血栓栓塞症诊治与预防指南[J]. 中华医学杂志, 2018, 98(14):1060-1086.
[2] Steinberg BA, Peterson ED, Kim S, et al. Use and outcomes associated with bridging during anticoagulation interruptions in patients with atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)[J]. Circulation, 2015, 131(5):488-494.
[3] Le Gal G, Kercret G, Ben Yahmed K, et al. Diagnostic value of single complete compression ultrasonography in pregnant and postpartum women with suspected deep vein thrombosis: prospective study[J]. BMJ, 2012, 344:e2635.
[4] Romualdi E, Dentali F, Rancan E, et al. Anticoagulant therapy for venous thromboembolism during pregnancy: a systematic review and a meta-analysis of the literature[J]. J Thromb Haemost, 2013, 11(2):270-281.
[5] Douma RA, van Sluis GL, Kamphuisen PW, et al. Clinical decision rule and D-dimer have lower clinical utility to exclude pulmonary embolism in cancer patients. Explanations and potential ameliorations[J]. Thromb Haemost, 2010, 104(4):831-836.
[6] Lee AYY, Kamphuisen PW, Meyer G, et al. Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer: A Randomized Clinical Trial[J]. JAMA, 2015, 314(7):677-686.
[7] Akl EA, Vasireddi SR, Gunukula S, et al. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer[J]. Cochrane Database Syst Rev, 2011,(6):CD006649.
[8] Condliffe R, Elliot CA, Hughes RJ, et al. Management dilemmas in acute pulmonary embolism[J]. Thorax, 2014, 69(2):174-180.
[9] Athappan G, Sengodan P, Chacko P, et al. Comparative efficacy of different modalities for treatment of right heart thrombi in transit: a pooled analysis[J]. Vasc Med, 2015, 20(2):131-138.
[10] Douketis JD, Spyropoulos AC, Spencer FA, et al. Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J]. Chest, 2012, 141(2 Suppl):e326S-e350S.
[11] Cuker A, Gimotty PA, Crowther MA, et al. Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis[J]. Blood, 2012, 120(20):4160-4167.
[12] Kelton JG, Arnold DM, Bates SM. Nonheparin anticoagulants for heparin-induced thrombocytopenia[J]. N Engl J Med, 2013, 368(8):737-744.
[13] Kang M, Alahmadi M, Sawh S, et al. Fondaparinux for the treatment of suspected heparin-induced thrombocytopenia: a propensity score-matched study[J]. Blood, 2015, 125(6):924-929.
文章导航

/